Tumour M2-PK as a predictor of surgical outcome in ovarian cancer, a prospective cohort study.

Abstract

TU M2-PK was significantly raised in ovarian cancer patients, particularly those with higher stage disease. The potential clinical application as a predictor of surgical outcome in ovarian cancer needs further evaluation.